Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients

February 15, 2017 updated by: Andrew Shaw, Vanderbilt University

Retrospective Analysis of Clinical Outcomes Associated With Use of the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients Within the Cerner HealthFacts Database

The primary objective for this retrospective Electronic Health Record (EHR) analysis is to evaluate the clinical outcomes associated with the utilization of a pulmonary artery catheter (PAC), for monitoring purposes, within patients undergoing cardiac surgeries (isolated coronary artery bypass graft [CABG], valve, aortic surgery, multi-procedures, other complex nonvalvular procedures and heart transplants). The study will be conducted using prospectively collected hospital inpatient data over a duration of over 5 years (Jan. 1, 2010 - June 30, 2015) using a large US electronic health database (Cerner HealthFacts; Kansas City, MO).

Study Overview

Detailed Description

A retrospective study will be conducted using prospectively collected hospital inpatient data over a duration of over 5 years (Jan. 1, 2010 - June 30, 2015) using a large US electronic health database (Cerner HealthFacts; Kansas City, MO). Patients who underwent a qualifying cardiac surgery (verified through use of selected valid International Classification of Diseases-9 procedure codes and/or Current Procedural Terminology [CPT] codes) will be included. Each patient's cohort designation will be defined based upon whether he/she did or did not receive a pulmonary artery catheter (PAC) for monitoring purposes. Propensity scores, which take into account patient and hospital demographics, patient comorbidities, surgical type (isolated coronary artery bypass graft [CABG], valve, aortic surgery, multi-procedures, other complex nonvalvular procedures and heart transplants), and pre-operative condition (via an adapted EuroSCORE II) will be utilized to "match" patients who received a PAC for monitoring purposes with those who did not, to form a matched study cohort. Clinical outcomes will be monitored through index visit discharge and up to 90 days post index visit discharge.

Study Type

Observational

Enrollment (Actual)

6844

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult patients undergoing an isolated CABG, isolated valve, aortic procedure, complex nonvalvular procedures, multi-procedures or a heart transplant who receives or does not receive a pulmonary artery catheter (PAC) for monitoring purposes

Description

Inclusion Criteria:

  • Patient undergoes a qualifying cardiac surgery between Jan 1, 2010 and January 1, 2015. If multiple qualifying surgeries are present, the first in database will be utilized
  • Inpatient with a LOS of at least 48 hours
  • Treated arm receives a PAC for monitoring purposes within admission date and qualifying cardiac surgical day plus one via specified ICD-9 or CPT-4 codes, or EHR recorded PAC readings

Exclusion Criteria:

  • Cardiac surgery patients with age <18 years on index procedure date
  • Non-treated arm derived from an institution which does not have database documented use of ICD-9 or CPT-4 PAC placement codes for monitoring purposes [Lessens the likelihood that the untreated arm is indeed treated by ensuring that the patient would likely be coded if he/she had a PAC in place for monitoring purposes]
  • Patient record must have the demographics populated of age, gender, and race. ICD-9 diagnosis and procedure codes must be present in record for index visit, as well as medications administered over index visit
  • Patient must be treated at a hospital which performs a minimum of 100 qualifying cardiac procedures per year

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pulmonary artery catheter (PAC)
Patients received a PAC for monitoring purposes
PAC must be placed between the day of admission and the day following a qualifying cardiac surgery
Other Names:
  • Swan-Ganz catheter
No pulmonary artery catheter (PAC)
Patients did not receive a PAC for monitoring purposes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital mortality during index visit
Time Frame: Admission through up to 180 days (hospital discharge)
Admission through up to 180 days (hospital discharge)
Hospital length-of-stay (LOS)
Time Frame: Admission through up to 180 days (hospital discharge)
Index hospital visit LOS
Admission through up to 180 days (hospital discharge)
Hospital readmission
Time Frame: Through 30 days
Rate of hospital readmissions
Through 30 days
Hospital readmission
Time Frame: Through 60 days
Rate of hospital readmissions
Through 60 days
Hospital readmission
Time Frame: Through 90 days
Rate of hospital readmissions
Through 90 days
Major Adverse Cardiac Events (MACE)
Time Frame: Through 30 days
Through 30 days
Major Adverse Cardiac Events (MACE)
Time Frame: Through 60 days
Through 60 days
Major Adverse Cardiac Events (MACE)
Time Frame: Through 90 days
Through 90 days
Major morbidity composite
Time Frame: Through 30 days
Through 30 days
Major morbidity composite
Time Frame: Through 60 days
Through 60 days
Major morbidity composite
Time Frame: Through 90 days
Through 90 days

Secondary Outcome Measures

Outcome Measure
Time Frame
New organ failure (cardiovascular, respiratory, coagulation, liver systems, renal)
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)
Requirement for mechanical ventilation
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)
Hemorrhage requiring blood transfusion
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)
Acute kidney injury (KDIGO staging)
Time Frame: Day 1 to day 10
Day 1 to day 10
Infectious complications
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)
Gastrointestinal complication (hepatic)
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)
Respiratory failure
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)
Sequential Organ Failure Assessment (SOFA) scores
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)
Neurologic complication
Time Frame: Day 1 to discharge (up to 180 days)
Day 1 to discharge (up to 180 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Andrew D Shaw, MB, FRCA, FFICM, FCCM, Vanderbilt University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

November 1, 2016

Study Registration Dates

First Submitted

October 18, 2016

First Submitted That Met QC Criteria

November 10, 2016

First Posted (Estimate)

November 15, 2016

Study Record Updates

Last Update Posted (Actual)

February 17, 2017

Last Update Submitted That Met QC Criteria

February 15, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 161377

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Surgery

Clinical Trials on pulmonary artery catheter

Subscribe